2Robbins.Pathologic basis of disease[J].日本医学介绍,2005,26(4):163-165.
3Pankow JS,Folsom AR,Cushman M,et al.Familial and genetic determinants of systemic markers of inflammation:the NHLBI family heart study[J].Atherosclerosis,2001,32(154):681-689.
4Vickers MA,Green FR,Terry C,et al.Genotypeat a promoter polymorphism of the interleukin-6 gene is associated with baline levels of plasma C-reactive protein[J].Cardiovasc Res,2002,53(4):1029-1034.
5Zee R,Ridker P M.Polymorphism in the human C-reactive protein (CRP) gene,plasma concentrations of CRP and the risk of future arterial thrombosis[J].Atherosclerosis,2002,16(162):217-219.
2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
4Casoinic F,Smpelean D,Badǎu C.Glycoregulation disorders and alterations of C reactive protein in nonalcoholic fatty liver disease[J].Rom J Intern Med,2006,44(4):419-426.
5Senzolo M,Coppell J,Cholongitas E,et al.The effects of glycosaminoglycans on coagulation:a thromboelastographic study[J].Blood Coagul Fibrinolysis,2007,18(3):227-236.
6周新,涂植光.临床生物化学和生物化学检验[M].3版.北京:人民卫生出版社,2006:117.
7Cabibbo G, Craxl A. Epidemiology, risk factors and surveillance of hepatocellular carcinoma[ J]. Eur Rev Med Pharmacol Sci,2010, 14 (4) :352 -355.
